Not currently recruiting at UC Health
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
Summary
- Eligibility
- for people ages 2-35 (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
- ID
- NCT03355209
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated